This proposal tests the hypothesis that Globin mRNAs contain determinant(s) critical to their stability and their consequent rapid accumulation in the developing erythrocyte. During a 3-5 day window of erythroid differentiation, globin mRNAs increase from less than 0.1% to greater than 95% of total cellular mRNA. This accumulation is dependent on both transcriptional activation of the globin genes and the unusual stability of the encoded globin mRNAs in erythroid cells. We plan to investigate the structural basis for the stability of globin mRNA. Our starting point will be to study a naturally occurring alpha-thalassemia mutation; alphaConstant Spring (alphaCS). Our preliminary data demonstrates that this mutation of the normal translation termination codon (UAA-->CAA) of the alpha2-globin mRNA results in its destabilization. Preliminary data further suggests that this destabilization is mechanistically linked to the entry of the translating ribosome into the 3' nontranslated region. We will study this destabilization of CS mRNA in detail and use the findings to suggest the position and mode of action of putative stability determinants in native alpha2-globin mRNA. The experimental approach will be based upon transfections of alpha2-globin genes (native and derivative) into tissue culture cells (erythroid and non erythroid) and studying the effect of informative mutations (including CS) on the stability of the encoded mRNAs. Preliminary results from site-specific mutations indicate that positive determinants of alpha2-globin mRNA stability reside in the 3' NTR. Potential interactions of these structural determinants with trans-acting factors will also be explored. The results of these studies will be generalized to other globin mRNAs and to nonglobin mRNAs whose message levels change during erythroid differentiation in order to determine whether there exist shared regulatory mechanisms of mRNA stability. Data from these experiments will contribute to a fundamental understanding of globin gene expression essential in the formulation of molecular genetic approaches to the therapy of sickle cell anemia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038632-10
Application #
6241948
Study Section
Project Start
1997-04-01
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ballas, Samir K; Connes, Philippe; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (2018) Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and ?-thalassemia. Eur J Haematol 101:798-803
Kwiatkowski, Janet L; Zimmerman, Robert A; Pollock, Avrum N et al. (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146:300-5
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Kiryu, Shigeru; Sundaram, Tessa; Kubo, Shigeto et al. (2008) MRI assessment of lung parenchymal motion in normal mice and transgenic mice with sickle cell disease. J Magn Reson Imaging 27:49-56
Niebanck, Alison E; Pollock, Avrum N; Smith-Whitley, Kim et al. (2007) Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr 151:67-72, 72.e1
Uematsu, Hidemasa; Takahashi, Masaya; Hatabu, Hiroto et al. (2007) Changes in T1 and T2 observed in brain magnetic resonance imaging with delivery of high concentrations of oxygen. J Comput Assist Tomogr 31:662-5
Obata, Kazuo; Mattiello, Julian; Asakura, Kenji et al. (2006) Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes. Am J Hematol 81:26-35
Akbar, Mohammed G K; Tamura, Yutaka; Ding, Min et al. (2006) Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide. Biochemistry 45:8358-67
Adachi, Kazuhiko; Ding, Min; Surrey, Saul et al. (2006) The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism. J Mol Biol 362:528-38
Asakura, Toshio; Asakura, Kenji; Obata, Kazuo et al. (2005) Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 80:249-56

Showing the most recent 10 out of 140 publications